This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Becton Dickinson seeks stay of injunction in hypodermic syringe antitrust case

( December 8, 2014, 23:31 GMT | Official Statement) -- MLex Summary: Becton Dickinson filed an emergency motion to stay a mandatory injunction entered against it on Nov. 14 in a case accusing it of unlawfully maintaining a monopoly in the hypodermic syringe market. Becton wishes to stay the injunction pending an appeal and says that absent a stay it will be permanently harmed by the requirement that it notify its customers that it “wrongfully” distributed “false and misleading” advertisements concerning the sharpness of its needles. See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections